United States of America
Factsheet| EV/EBITDA Last | EV/EBITDA(e) 2025 | EV/EBITDA NTM | |
|---|---|---|---|
| Johnson & Johnson | Free trial | Free trial | Free trial |
| International Peers | Free trial | Free trial | Free trial |
| Pharmaceuticals | 3.99 | 7.05 | 6.96 |
| DJIA | 15.60 | 12.59 | 12.39 |
| United States of America | 5.06 | 8.11 | 8.21 |
Johnson & Johnson |
| Sector: Pharmaceuticals | Ticker: JNJ |
|
"The Risk Score is a relevant measure for the assessment of a stock attractiveness. Johnson & Johnson shows a Risk Score of 10.00.
0 corresponds to a very high risk and 10 corresponds to a very low risk."
The Risk Score for Johnson & Johnson is significantly higher than its peer group's. This means that Johnson & Johnson is significantly less risky than its peer group.
To analyze and assess the risk of a company, several indicators are important to look at including liquidity / volatility / debt level and capital structure. In GPRV, the aggregated Risk Score is the average of the risk indicators' scores.
Beta
The Beta is a quantitative measure of the volatility of a stock relatively to the volatility of the market. The Beta currently displayed is the 1 year Beta.
Volatility
Infront Analytics uses a method of estimating volatilities based on 3 months (62 business days) historical market value fluctuations.
Volume (3-Month daily average)
Volume indicator is the average of the daily volume over the last three months in $ millions.
Market Cap
Last close Market Capitalization in $ millions.
Net Debt/Market Cap
This is the Solvency measure, it guarantees that the company has a sound capital structure.
Calculation:
Last published net debt / Last market cap.